Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -29.055% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCCc1nc(SCC(=O)N2CCc3ccccc3C2)c2ccccc2n1
[b] COc1ccc(-c2cc(-c3ccccc3)nc(SCC(=O)Nc3ncc(C)s3)c2C#N)cc1
Answer: a. CCCc1nc(SCC(=O)N2CCc3ccccc3C2)c2ccccc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1nc(SCC(=O)N2CCc3ccccc3C2)c2ccccc2n1
CCCc1nc(SCC(=O)N2CCc3ccccc3C2)c2ccccc2n1
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-(2-propylquinazolin-4-yl)sulfanylethanone